Banerjee A K, Pearson J, Gilliland E L, Goss D, Lewis J D, Stirling Y, Meade T W
Department of Vascular Surgery, Northwick Park Hospital, Harrow, United Kingdom.
Thromb Haemost. 1992 Sep 7;68(3):261-3.
A total of 333 patients with stable intermittent claudication at recruitment were followed up for 6 years to determine risk factors associated with subsequent mortality. Cardiovascular diseases were the underlying cause of death in 78% of the 114 patients who died. The strongest independent predictor of death during the follow-up period was the plasma fibrinogen level, an increase of 1 milligram being associated with a nearly two-fold increase in the probability of death within the next 6 years. Age, low ankle/brachial pressure index and a past history of myocardial infarction also increased the probability of death during the study period. The plasma fibrinogen level is a valuable index of those patients with stable intermittent claudication at high risk of early mortality. The results also provide further evidence for the involvement of fibrinogen in the pathogenesis of arterial disease.
共有333例招募时患有稳定型间歇性跛行的患者接受了6年随访,以确定与随后死亡率相关的危险因素。在114例死亡患者中,78%的潜在死因是心血管疾病。随访期间死亡的最强独立预测因素是血浆纤维蛋白原水平,每增加1毫克,未来6年内死亡概率几乎增加两倍。年龄、低踝/臂压力指数和心肌梗死病史也增加了研究期间的死亡概率。血浆纤维蛋白原水平是稳定型间歇性跛行患者早期死亡高风险的一个有价值指标。这些结果也为纤维蛋白原参与动脉疾病发病机制提供了进一步证据。